Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Your voice may reveal early dementia: new AI tool tested

NCT ID NCT07553117

Diagnosis Sponsor: Accexible Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a machine learning tool called Accexible that analyzes speech to detect mild cognitive impairment (MCI), an early stage of memory loss. Researchers compared it to a standard pencil-and-paper test in 114 older adults in Colombia. The goal was to see if the voice-based tool could accurately identify MCI, potentially offering a simpler way to catch memory problems early.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Accexible speech analysis tool (device)
What this could lead to
If successful, this could provide a simple, non-invasive way to detect early memory problems using just a voice recording.
What could go wrong
This is a small, completed study in one country. The tool may not work as well in other populations or settings, and it is not a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

114 people

The number who actually took part.

Started

May 2022

Finished

Jun 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults aged \>60 years attending in-person primary care consultations within the EPS Sanitas network (Bogotá, Colombia).

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Ability to independently operate a mobile or portable device with internet connectivity and integrated microphone * Provision of voluntary written informed consent prior to study participation Exclusion Criteria: * Diagnosed psychiatric disorder or cognitive impairment not attributable to neurodegenerative etiology * Visual impairment sufficient to preclude reading on-screen text or perceiving visual stimuli * Illiteracy * Hearing impairment sufficient to preclude comprehension of verbal instructions or detection of auditory test-onset cues

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MCI are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MCI

Contacts and locations

Locations

  • Fundación Universitaria Sanitas

    Bogotá, 110911, Colombia

More trials for these conditions

Other studies related to the condition(s) this trial covers.